Understanding Fluidized-Bed Granulation - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Understanding Fluidized-Bed Granulation
This study demonstrates the beneficial use of a spatial-filter velocimetry particle-size analyzer during granulation.


Pharmaceutical Technology
Volume 35, Issue 8, pp. 63-67

References

1. S.M. Iveson, et al., Powder Technol. 117 (1–2), 3–39 (2001).

2. T. Naervanen, et al., AAPS PharmSciTech 9 (1), 282–287 (2008).

3. S. Watano, Powder Technol. 117 (1–2), 163–172 (2001).

4. S. Watano and K. Miyanami, Powder Technol. 83 (1), 55–60 (1995).

5. S. Watano et al., Chem. Pharm. Bull. 48 (8), 1154–1159 (2000).

6. S. Watano et al., Powder Technol. 115 (2), 124–130 (2001).

7. S. Watano, Y. Sato, and K. Miyanami, Chem. Pharm. Bull. 44 (8), 1556–1560 (1996).

8. S. Watano, Y. Sato, and K. Miyanami, Adv. Powder. Technol. 8 (4), 269–277 (1997).

9. M. Alcala et al., J. Pharm. Sci. 99 (1), 336–345 (2010).

10. W.P. Findlay, G.R. Peck, and K.R. Morris, J. Pharm. Sci. 94 (3), 604–612 (2005).

11. P. Frake et al., Int. J. Pharm. 151 (1), 75–80 (1997).

12. S.G. Goebel and K.J. Steffens, Pharm. Industrie 60 (10), 889–895 (1998).

13. A.A. Kaddour and B. Cuq, Powder Technol. 190 (1–2), 10–18 (2009).

14. P. Luukkonen et al., J. Pharm. Sci. 97 (2), 950–959 (2008).

15. A. Tok et al., AAPS PharmSciTech 9 (4), 1083–1091 (2008).

16. J.F. Gamble, A.B. Dennis, and M. Tobyn, Pharm. Dev. Technol. 14 (3), 299–304 (2009).

17. M. Halstensen, P. de Bakker, and K.H. Esbensen, Chemom. Intell. Lab. Syst. 84 (1–2), 88–97 (2006).

18. S. Matero et al., Chemom. Intell. Lab. Syst. 97 (1), 75–81 (2009).

19. M. Whitaker et al., Int. J. Pharm. 205 (1–2), 79–91 (2000).

20. X.H. Hu, J.C. Cunningham, and D. Winstead, Int. J. Pharm. 347 (1–2), 54–61 (2008).

21. J. Huang et al., J. Pharm. Sci. 99 (7), 3205–3212 (2010).

22. T. Lipsanen et al., AAPS PharmSciTech. 9 (4), 1070–1077 (2008).

23. T. Narvanen et al., J. Pharm. Sci. 98 (3), 1110–1117 (2009).

24. T. Narvanen et al., Int. J. Pharm. 357 (1–2), 132-138 (2008).

Citation: When referring to this article, please cite it as "A. Burggraeve, T. Van Den Kerkhof, M. Hellings, J.P. Remon, C. Vervaet, T. De Beer, "Understanding Fluidized-Bed Granulation," Pharmaceutical Technology 35 (8) 63-67(2011)."


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here